Characterization of BRCA Deficiency in Ovarian Cancer

SIMPLE SUMMARY: Ovarian cancer (OC) is a highly lethal malignancy. Major improvements in treatment are expected from the identification of molecular features that may predict outcome or be used as therapeutic targets. Among genetic defects relevant for OC are those of BRCA1 and BRCA2 genes. Indeed,...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbero, Giovanna, Zuntini, Roberta, Magini, Pamela, Desiderio, Laura, Bonaguro, Michela, Perrone, Anna Myriam, Rubino, Daniela, Grippa, Mina, De Leo, Antonio, Ceccarelli, Claudio, Godino, Lea, Miccoli, Sara, Ferrari, Simona, Santini, Donatella, De Iaco, Pierandrea, Zamagni, Claudio, Innella, Giovanni, Turchetti, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001116/
https://www.ncbi.nlm.nih.gov/pubmed/36900320
http://dx.doi.org/10.3390/cancers15051530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001116/
https://www.ncbi.nlm.nih.gov/pubmed/36900320
http://dx.doi.org/10.3390/cancers15051530

Ejemplares similares